195 related articles for article (PubMed ID: 24633919)
21. [Experimental study of dendritic cells transfected with cancer stem like cells RNA against 9L brain tumors].
Xiao ZY; Chen XJ; Yang Y; Xu RX
Beijing Da Xue Xue Bao Yi Xue Ban; 2015 Aug; 47(4):661-6. PubMed ID: 26284406
[TBL] [Abstract][Full Text] [Related]
22. A rat glioma model, CNS-1, with invasive characteristics similar to those of human gliomas: a comparison to 9L gliosarcoma.
Kruse CA; Molleston MC; Parks EP; Schiltz PM; Kleinschmidt-DeMasters BK; Hickey WF
J Neurooncol; 1994; 22(3):191-200. PubMed ID: 7760095
[TBL] [Abstract][Full Text] [Related]
23. Selective enhancement of radiation response of herpes simplex virus thymidine kinase transduced 9L gliosarcoma cells in vitro and in vivo by antiviral agents.
Kim JH; Kim SH; Kolozsvary A; Brown SL; Kim OB; Freytag SO
Int J Radiat Oncol Biol Phys; 1995 Nov; 33(4):861-8. PubMed ID: 7591895
[TBL] [Abstract][Full Text] [Related]
24. Analysis of interleukin 2 and various effector cell populations in adoptive immunotherapy of 9L rat gliosarcoma: allogeneic cytotoxic T lymphocytes prevent tumor take.
Kruse CA; Lillehei KO; Mitchell DH; Kleinschmidt-DeMasters B; Bellgrau D
Proc Natl Acad Sci U S A; 1990 Dec; 87(24):9577-81. PubMed ID: 2263613
[TBL] [Abstract][Full Text] [Related]
25. An experimental study of dendritic cells transfected with cancer stem-like cells RNA against 9L brain tumors.
Xiao ZY; Tang H; Xu ZM; Yan ZJ; Li P; Cai YQ; Jiang XD; Xu RX
Cancer Biol Ther; 2011 Jun; 11(11):974-80. PubMed ID: 21502808
[TBL] [Abstract][Full Text] [Related]
26. Microglia phagocytose alloreactive CTL-damaged 9L gliosarcoma cells.
Kulprathipanja NV; Kruse CA
J Neuroimmunol; 2004 Aug; 153(1-2):76-82. PubMed ID: 15265665
[TBL] [Abstract][Full Text] [Related]
27. lacZ transduction of 9L rat tumor cells without cloning.
Gabryel-Grudziak A; Boggs SS; Redgate ES; Deutsch M
Tumour Biol; 1997; 18(6):321-31. PubMed ID: 9372865
[TBL] [Abstract][Full Text] [Related]
28. Cytokine gene therapy of gliomas: effective induction of therapeutic immunity to intracranial tumors by peripheral immunization with interleukin-4 transduced glioma cells.
Okada H; Villa L; Attanucci J; Erff M; Fellows WK; Lotze MT; Pollack IF; Chambers WH
Gene Ther; 2001 Aug; 8(15):1157-66. PubMed ID: 11509946
[TBL] [Abstract][Full Text] [Related]
29. Irradiation of intracerebral 9L gliosarcoma by a single array of microplanar x-ray beams from a synchrotron: balance between curing and sparing.
Regnard P; Le Duc G; Bräuer-Krisch E; Troprès I; Siegbahn EA; Kusak A; Clair C; Bernard H; Dallery D; Laissue JA; Bravin A
Phys Med Biol; 2008 Feb; 53(4):861-78. PubMed ID: 18263945
[TBL] [Abstract][Full Text] [Related]
30. Characterization of gastrin-induced cytostatic effect on cell proliferation in experimental malignant gliomas.
Lefranc F; Sadeghi N; Metens T; Brotchi J; Salmon I; Kiss R
Neurosurgery; 2003 Apr; 52(4):881-90; discussion 890-1. PubMed ID: 12657185
[TBL] [Abstract][Full Text] [Related]
31. Expression of a soluble transforming growth factor-beta (TGFbeta) receptor reduces tumorigenicity by regulating natural killer (NK) cell activity against 9L gliosarcoma in vivo.
Witham TF; Villa L; Yang T; Pollack IF; Okada H; Robbins PD; Chambers WH
J Neurooncol; 2003; 64(1-2):63-9. PubMed ID: 12952287
[TBL] [Abstract][Full Text] [Related]
32. Immunotherapy with bovine aortic endothelial cells in subcutaneous and intracerebral glioma models in rats: effects on survival time, tumor growth, and tumor neovascularization.
Corsini E; Gelati M; Calatozzolo C; Alessandri G; Frigerio S; De Francesco M; Poiesi C; Parati E; Croci D; Boiardi A; Salmaggi A
Cancer Immunol Immunother; 2004 Nov; 53(11):955-62. PubMed ID: 15449042
[TBL] [Abstract][Full Text] [Related]
33. Copper chelation inhibits tumor angiogenesis in the experimental 9L gliosarcoma model.
Yoshida D; Ikeda Y; Nakazawa S
Neurosurgery; 1995 Aug; 37(2):287-92; discussion 292-3. PubMed ID: 7477781
[TBL] [Abstract][Full Text] [Related]
34. Multimodality imaging of abnormal vascular perfusion and morphology in preclinical 9L gliosarcoma model.
Darpolor MM; Molthen RC; Schmainda KM
PLoS One; 2011 Jan; 6(1):e16621. PubMed ID: 21305001
[TBL] [Abstract][Full Text] [Related]
35. Long-term immunological memory in the resistance of rats to transplanted intracerebral 9L gliosarcoma (9LGS) following subcutaneous immunization with 9LGS cells.
Smilowitz HM; Joel DD; Slatkin DN; Micca PL; Nawrocky MM; Youngs K; Tu W; Coderre JA
J Neurooncol; 2000; 46(3):193-203. PubMed ID: 10902851
[TBL] [Abstract][Full Text] [Related]
36. Post-acute response of 9L gliosarcoma to Photofrin-mediated PDT in athymic nude mice.
Zhang X; Jiang F; Kalkanis SN; Zhang Z; Hong X; Yang H; Chopp M
Lasers Med Sci; 2007 Nov; 22(4):253-9. PubMed ID: 17505777
[TBL] [Abstract][Full Text] [Related]
37. Liposome-mediated therapy of intracranial brain tumors in a rat model.
Sharma US; Sharma A; Chau RI; Straubinger RM
Pharm Res; 1997 Aug; 14(8):992-8. PubMed ID: 9279878
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of the bystander effect in experimental brain tumors bearing herpes simplex virus-thymidine kinase gene by serial magnetic resonance imaging.
Namba H; Iwadate Y; Tagawa M; Kimura M; Shimizu H; Sato Y; Sueyoshi K; Sakiyama S
Hum Gene Ther; 1996 Oct; 7(15):1847-52. PubMed ID: 8894676
[TBL] [Abstract][Full Text] [Related]
39. Gene transfer into experimental brain tumors mediated by adenovirus, herpes simplex virus, and retrovirus vectors.
Boviatsis EJ; Chase M; Wei MX; Tamiya T; Hurford RK; Kowall NW; Tepper RI; Breakefield XO; Chiocca EA
Hum Gene Ther; 1994 Feb; 5(2):183-91. PubMed ID: 8186298
[TBL] [Abstract][Full Text] [Related]
40. Fractionated radiosurgery for 9L gliosarcoma in the rat brain.
Kim JH; Khil MS; Kolozsvary A; Gutierrez JA; Brown SL
Int J Radiat Oncol Biol Phys; 1999 Nov; 45(4):1035-40. PubMed ID: 10571213
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
